WAYNE, Pa., June 22, 2011 (GLOBE NEWSWIRE) -- After more than a decade of continued growth, Octagon Research Solutions, Inc. is expanding globally by adding 100 clinical and regulatory professionals. To accommodate this growth, Octagon is expanding its US Headquarters location, and broadening its presence in Europe and in the Asia-Pacific region with new facilities in the UK and in India. Octagon's continued growth is a direct result of the biopharmaceutical industry's drive toward clinical and regulatory efficiencies that impact cost, resources and regulatory submission timelines on a global scale. Octagon is already working with 60% of the top-50 global pharmaceutical companies and hundreds of additional biopharmaceutical clients across all tiers and geographies.
"Octagon Research Solutions, Inc. global expansion demonstrates our ongoing commitment to supporting our valued clients with region-specific regulatory experts and to expanding Octagon's business in new regions around the world," said James C. Walker, chairman and CEO, Octagon Research Solutions, Inc. "With our client portfolio growing more than 20% just this year and growth projections well beyond that for 2012, Octagon's global expansion supports the robust demand for our clinical and regulatory software solutions and services."
The life sciences industry has taken a close look at clinical and regulatory processes and is partnering with organizations such as Octagon who specialize in clinical and regulatory technologies and have deep regulatory domain expertise. Octagon's expansion will allow the company to operate even more efficiently on a global level and deliver value to its clients in their time zones with localized knowledge, presence, behavior and expectations.
Earlier this week Octagon announced two novel additions to its Quantum Regulatory Information Management platform being previewed at the DIA 2011 47th Annual Meeting in Chicago, IL.
About Octagon Research Solutions
Octagon is a pioneer and leading provider of breakthrough software and services to the life sciences industry. Octagon's eCTD and CDISC solutions provide the people, process, and technology required to optimize drug development from data collection to submission. Octagon's clinical, process, and software offerings provide a unique combination of deep domain knowledge, cross-functional electronic submission expertise, and a holistic process approach and integrated solutions. Octagon is headquartered in Wayne, Pennsylvania with European offices in London, UK and Asia-Pacific offices in Bangalore, India. Octagon's EDC Operations are located in Mountain View, California. For more information please visit www.octagonresearch.com.